-
1
-
-
58149389215
-
Glucose control and vascular complications in veterans with type 2 diabetes
-
VADT Investigators
-
VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360:129-139.
-
(2009)
N Engl J Med
, vol.360
, pp. 129-139
-
-
-
2
-
-
45149133036
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
-
ADVANCE Collaborative Group
-
ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572.
-
(2008)
N Engl J Med
, vol.358
, pp. 2560-2572
-
-
-
3
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
ACCORD Study Group
-
ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-2559
-
(2008)
N Engl J Med
, vol.358
, pp. 2545-2559
-
-
-
4
-
-
0028008336
-
Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
-
McGill JB, Schneider DJ, Arfken CL, Lucore LC, Sobel BE. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 1994; 43:104-109.
-
(1994)
Diabetes
, vol.43
, pp. 104-109
-
-
McGill, J.B.1
Schneider, D.J.2
Arfken, C.L.3
Lucore, L.C.4
Sobel, B.E.5
-
5
-
-
44949088433
-
Metabolic syndrome, haemostasis and thrombosis
-
Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 2008; 99:995-1000.
-
(2008)
Thromb Haemost
, vol.99
, pp. 995-1000
-
-
Alessi, M.C.1
Juhan-Vague, I.2
-
6
-
-
33749052752
-
PAI-1 and the metabolic syndrome Links, causes, and consequences
-
Alessi M, Juhan-Vague I. PAI-1 and the metabolic syndrome. Links, causes, and consequences. Arterioscler Thromb Vasc Biol 2006; 26:2200-2207.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 2200-2207
-
-
Alessi, M.1
Juhan-Vague, I.2
-
7
-
-
2942530422
-
Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription
-
Vulin AJ, Stanley FM. Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J Biol Chem 2004; 279:25172-25178.
-
(2004)
J Biol Chem
, vol.279
, pp. 25172-25178
-
-
Vulin, A.J.1
Stanley, F.M.2
-
8
-
-
0022354051
-
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
-
Hamsten A, Wiman B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313:1557-1563.
-
(1985)
N Engl J Med
, vol.313
, pp. 1557-1563
-
-
Hamsten, A.1
Wiman, B.2
De Faire, U.3
Blomback, M.4
-
9
-
-
3242749003
-
Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type-1 (PAI-1)
-
Schneider DJ, Hayes M, Wadsworth M, Taatjes H, Rincon M, Taatjes DJ, Sobel BE. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type-1 (PAI-1). J Histochem Cytochem 2004; 52:1091-1099.
-
(2004)
J Histochem Cytochem
, vol.52
, pp. 1091-1099
-
-
Schneider, D.J.1
Hayes, M.2
Wadsworth, M.3
Taatjes, H.4
Rincon, M.5
Taatjes, D.J.6
Sobel, B.E.7
-
10
-
-
0033580594
-
Increased plasminogen activator inhibitor-1 and vasculopathy: A reconcilable paradox
-
Sobel BE. Increased plasminogen activator inhibitor-1 and vasculopathy: a reconcilable paradox. Circulation 1999; 99:2496-2498.
-
(1999)
Circulation
, vol.99
, pp. 2496-2498
-
-
Sobel, B.E.1
-
11
-
-
58149109143
-
Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1
-
Sato Y, Dong J, Imagawa S, Ishimori N, Furumoto T, Tsutsui H, et al. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1. Coron Artery Dis 2008; 19:355-361.
-
(2008)
Coron Artery Dis
, vol.19
, pp. 355-361
-
-
Sato, Y.1
Dong, J.2
Imagawa, S.3
Ishimori, N.4
Furumoto, T.5
Tsutsui, H.6
-
12
-
-
0036785795
-
Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes
-
Delbosc S, Morena M, Djouad F, Ledoucen C, Descomps B, Cristol JP. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J Cardiovasc Pharmacol 2002; 40:611-617.
-
(2002)
J Cardiovasc Pharmacol
, vol.40
, pp. 611-617
-
-
Delbosc, S.1
Morena, M.2
Djouad, F.3
Ledoucen, C.4
Descomps, B.5
Cristol, J.P.6
-
13
-
-
33749019757
-
Simvastatin improves diabetes-induced coronary endothelial dysfunction
-
Tawfik HE, El-Remessy AB, Matragoon S, Ma G, Caldwell RB, Caldwell RW. Simvastatin improves diabetes-induced coronary endothelial dysfunction. J Pharmacol Exp Ther 2006; 319:386-395.
-
(2006)
J Pharmacol Exp Ther
, vol.319
, pp. 386-395
-
-
Tawfik, H.E.1
El-Remessy, A.B.2
Matragoon, S.3
Ma, G.4
Caldwell, R.B.5
Caldwell, R.W.6
-
14
-
-
20944447650
-
Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/Enhancer-binding protein-d
-
Dong J, Fujii S, Li H, Nakabayashi H, Sakai M, Nishi S, et al. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/Enhancer-binding protein-d. Arterioscler Thromb Vasc Biol 2005; 25:1078-1084.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 1078-1084
-
-
Dong, J.1
Fujii, S.2
Li, H.3
Nakabayashi, H.4
Sakai, M.5
Nishi, S.6
-
15
-
-
0023937182
-
Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences
-
Bosma PJ, van den Berg EA, Kooistra T, Siemieniak DR, Slightom JL. Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences. J Biol Chem 1988; 263:9129-9141.
-
(1988)
J Biol Chem
, vol.263
, pp. 9129-9141
-
-
Bosma, P.J.1
Van Den Berg, E.A.2
Kooistra, T.3
Siemieniak, D.R.4
Slightom, J.L.5
-
16
-
-
0027312110
-
Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA
-
Fattal PG, Billadello JJ. Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA. Nucleic Acids Res 1993; 21:1463-1466.
-
(1993)
Nucleic Acids Res
, vol.21
, pp. 1463-1466
-
-
Fattal, P.G.1
Billadello, J.J.2
-
17
-
-
0025827561
-
Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type 1: Implications for vascular disease in hyperinsulinemic states
-
Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type 1: implications for vascular disease in hyperinsulinemic states. Proc Natl Acad Sci U S A 1991; 88:9959-9963.
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, pp. 9959-9963
-
-
Schneider, D.J.1
Sobel, B.E.2
-
18
-
-
0026651718
-
Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells
-
Schneider DJ, Nordt TK, Sobel BE. Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes 1992; 41:890-895.
-
(1992)
Diabetes
, vol.41
, pp. 890-895
-
-
Schneider, D.J.1
Nordt, T.K.2
Sobel, B.E.3
-
19
-
-
0026762333
-
Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulinlike growth factor 1
-
Fattal PG, Schneider DJ, Sobel BE, Billadello JJ. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulinlike growth factor 1. J Biol Chem 1992; 267:12412-12415.
-
(1992)
J Biol Chem
, vol.267
, pp. 12412-12415
-
-
Fattal, P.G.1
Schneider, D.J.2
Sobel, B.E.3
Billadello, J.J.4
-
20
-
-
0034740869
-
The role of 30-untranslated region mediated mRNA stability in cardiovascular pathophysiology
-
Misquitta CM, Iyer VR,Werstiuk ES, Grover AK. The role of 30-untranslated region mediated mRNA stability in cardiovascular pathophysiology. Mol Cell Biochem 2001; 224:53-67.
-
(2001)
Mol Cell Biochem
, vol.224
, pp. 53-67
-
-
Misquitta, C.M.1
Iyer, V.R.2
Werstiuk, E.S.3
Grover, A.K.4
-
21
-
-
0038150766
-
Posttranscriptional regulation of PAI-1 gene expression
-
Heaton JH, Dlakic WM, Gelehrter TD. Posttranscriptional regulation of PAI-1 gene expression. Thromb Haemost 2003; 89:959-966.
-
(2003)
Thromb Haemost
, vol.89
, pp. 959-966
-
-
Heaton, J.H.1
Dlakic, W.M.2
Gelehrter, T.D.3
-
22
-
-
22144484438
-
Involvement of adenylyl cyclase signaling mechanism in insulin and IGF-I coregulation of fundamental cell processes
-
Pertseva MN. Involvement of adenylyl cyclase signaling mechanism in insulin and IGF-I coregulation of fundamental cell processes. Ann N Y Acad Sci 2005; 1040:429-430.
-
(2005)
Ann N y Acad Sci
, vol.1040
, pp. 429-430
-
-
Pertseva, M.N.1
-
23
-
-
33846991976
-
Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase
-
Biswas S, Gupta MK, Chattopadhyay D, Mukhopadhyay CK. Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase. Am J Physiol Heart Circ Physiol 2007; 292:758-766.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
, pp. 758-766
-
-
Biswas, S.1
Gupta, M.K.2
Chattopadhyay, D.3
Mukhopadhyay, C.K.4
-
24
-
-
0242407768
-
Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis
-
Sobel BE, Taatjes DJ, Schneider DJ. Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23:1979-1989.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 1979-1989
-
-
Sobel, B.E.1
Taatjes, D.J.2
Schneider, D.J.3
-
27
-
-
0030480352
-
Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids
-
Schneider DJ, Sobel BE. Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids. Coron Artery Dis 1996; 7:813-817.
-
(1996)
Coron Artery Dis
, vol.7
, pp. 813-817
-
-
Schneider, D.J.1
Sobel, B.E.2
|